Tony Arnold, President & CEO
Greg Paul, Ph.D., Director of Health & Nutrition
Jonathan McIntyre, Ph.D, Vice President of Research and Development

Tony Arnold
President & CEO
Tony L. Arnold is president & chief executive officer of The Solae Company, a joint venture between DuPont and Bunge. During his tenure at the helm of The Solae Company, the organization has experienced double digit growth and reached $1 billion in sales in 2004.

Prior to his appointment, Mr. Arnold was vice president of marketing for the DuPont Agriculture and Nutrition business.

Before that, Mr. Arnold served as group vice president for BASF Global Agricultural Products and was responsible for global marketing and business development. He also served as the co-lead during the integration of the American Cyanamid business.

Earlier in his career, Mr. Arnold served as vice president of global marketing for American Cyanamid Company, in addition to a variety of domestic and international roles including marketing, sales, technical, and management positions during his 19 years of employment.

A graduate of the University of Tennessee, he earned both bachelor’s and master’s degrees in plant and soil sciences.

Greg Paul, Ph.D.
Director of Health & Nutrition
In 2003, Greg Paul, Ph.D., became director of Health and Nutrition and for The Solae Company, an alliance between DuPont and Bunge Limited. As director, Dr. Paul is responsible for overseeing and guiding The Solae Company’s research program, which includes supporting research that explores the health benefits of soy. In his role, Dr. Paul was an instrumental part of the team that examined and compiled research for a health claim petition linking the consumption of soy protein-based foods and the reduced risk of developing certain types of cancer.

Prior to joining The Solae Company, Dr. Paul held the position of director of nutrition science for Central Soya for several years. He also was the director of research and development, which included product, applications and technical development around soy protein and soy lecithin products. Previously, Dr. Paul spent many years with Quaker (now a division of PepsiCo, Inc.) as director of clinical research where he worked to communicate the health benefits of oats to the marketplace. The 1997 FDA-approved health claim linking the soluble fiber in oats to a reduced risk of heart disease was an important message in the company’s communications initiative.

Dr. Paul received a bachelor’s degree in education and a master’s degree in exercise physiology from Ohio State University. Dr. Paul went on to earn his Ph.D. from the University of Illinois –Urbana-Champaign. In 1996, Dr. Paul finished post-doctoral work in molecular biology. Currently, Dr. Paul is a fellow with Institute of Food Technologists and the American College of Nutrition. He is a member of the American Society of Clinical Nutrition and the American Society for Nutrition Sciences.

Jonathan McIntyre, Ph.D
Vice President of Research and Development

Jonathan McIntyre Ph.D is the vice president of research and development for The Solae Company. Dr. McIntyre is responsible for research and development, quality assurance and regulatory affairs. As the leader of the global R&D team, he plays a critical role in enabling the company to fulfill its vision of providing innovative soy-based ingredients that solve the needs of the company’s customers and consumers.

A well-known research and development professional with experience in the pharmaceutical, biotechnology and nutrition industries, Dr. McIntyre joined The Solae Company after serving as chief of development and operations at Auxeris Therapeutics, a discovery stage biopharmaceutical company developing drugs for bone diseases. Prior to that, he was chief scientist for Monsanto Protein Technologies, which focused on contract manufacturing of therapeutic proteins utilizing corn seed as a production host.

Dr. McIntyre began his career at Monsanto as a discovery scientist with G.D. Searle’s Cardiovascular Disease Research Group, where he contributed to the discovery of several clinical candidates. He was an integral part of Monsanto’s Nutrition Division, where he held a series of positions, most notably, director of product development. In that role, Dr. McIntyre led multiple projects including programs on plant sterols, omega three fatty acids and milk derived protein-peptide products for managing blood pressure.

A graduate of Grove City College with a bachelor’s degree in chemistry, he earned his doctorate degree in biochemistry and completed a post-doctoral fellowship from the University of Cincinnati College of Medicine.